Lymphoma is a common malignant
tumor globally.
Tumor-derived extracellular vesicles (Evs) participate in genetic information exchange between
tumor cells. We investigated the role and mechanism of human
Burkitt lymphoma cells Raji-derived Evs (Raji-Evs) in
lymphoma cells. Effects of Evs on
lymphoma cell proliferation, invasion, autophagy, and apoptosis were assessed using Cell Counting Kit-8 method, Transwell assay,
laser confocal microscopy, Western blotting, and flow cytometry.
microRNA (miR)-106a expression in
lymphoma cells was determined using reverse transcription-quantitative polymerase chain reaction and then downregulated in Raji cells and then Evs were isolated (Evs-in-miR-106a) to evaluate its role in
lymphoma cell growth. The binding relationship between miR-106a and
Beclin1 was verified using
RNA pull-down and dual-
luciferase assays.
Beclin1 was overexpressed in SU-DHL-4 and Farage cells and SU-DHL-4 cell autophagy and apoptosis were detected. The levels of miR-106a and
Beclin1 in SU-DHL-4 cells were detected after adding autophagy inhibitors. The tumorigenicity assay in nude mice was performed to validate the effects of Raji-Evs in vivo. Raji-Evs promoted
lymphoma cell proliferation and invasion and increased miR-106a. miR-106a knockdown reversed Evs-promoted
lymphoma cell proliferation and invasion. miR-106a carried by Raji-Evs targeted
Beclin1 expression.
Beclin1 overexpression or miR-106a inhibitor reversed the effects of Evs on
lymphoma cell autophagy and apoptosis. Autophagy inhibitors elevated miR-106a expression and lowered
Beclin1 expression. Raji-Evs-carried miR-106a inhibited Beclin1-dependent autophagy and apoptosis in
lymphoma cells, which were further verified in vivo, together with promoted
tumor growth. We proved that Raji-Evs inhibited
lymphoma cell autophagy and apoptosis and promoted cell growth via the miR-106a/
Beclin1 axis.